Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jieli Bao"'
Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis
Publikováno v:
Analytical Cellular Pathology, Vol 2023 (2023)
Background. In the present study, we aimed to find out whether luteolin (Lut) pretreatment could ameliorate myocardial ischemia/reperfusion (I/R) injury by regulating the lncRNA just proximal to XIST (JPX)/microRNA-146b (miR-146b) axis. Methods. We e
Externí odkaz:
https://doaj.org/article/067b8b8a2dc543c6a3bb83152e676ec1
Autor:
Tao Liu, Chaofan Wang, Jie Yin, Lili Wang, Haochen Xuan, Yan Yan, Junhong Chen, Jieli Bao, Dongye Li, Tongda Xu
Publikováno v:
Therapeutics and Clinical Risk Management. 18:813-823
Tao Liu,* Chaofan Wang,* Jie Yin, Lili Wang, Haochen Xuan, Yan Yan, Junhong Chen, Jieli Bao, Dongye Li, Tongda Xu Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Peopleâs Republic of China*Thes
Autor:
Jieli Bao, Chengmeng Zhang, Junhong Chen, Haochen Xuan, Chaofan Wang, Shaoshen Wang, Jie Yin, Yang Liu, Dongye Li, Tongda Xu
Publikováno v:
Experimental Cell Research. 427:113572
Publikováno v:
Pharmacological Research. 169:105573
Pharmacotherapies, including angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor II blockers (ARBs), β-blockers (BBs), mineralocorticoid receptor antagonists (MRAs) and angiotensin receptor blocker-neprilysin inhibitor (ARNI), hav